Latest Strategic Growth News

Deterra Royalties reported a robust 44% jump in quarterly revenue to $89.1 million, driven by record iron ore royalties and advancing lithium project construction. The company’s diversified portfolio and strategic investments position it well for long-term growth.

Brookside Energy Limited reported a strong quarter with the Bruins well commencing production, solid contributions from Gapstow wells, and a disciplined capital strategy including a new share buy-back program.

Rio Tinto reported robust half-year results with $11.5 billion underlying EBITDA, advancing key projects and completing a major lithium acquisition amid challenging market conditions.

Rewardle Holdings has reinforced its strategic position by increasing its stake in CloudHolter following a $100 million capital raise, while progressing towards ASX relisting after resolving financial reporting delays.

RemSense Technologies closed FY2025 with a positive EBITDA and expanding virtualplant platform usage among major clients, setting the stage for significant growth in FY2026. The company’s strategic hires and new contracts highlight its rising footprint in industrial digital transformation.

Environmental Clean Technologies Limited has secured crucial regulatory approvals for its Bacchus Marsh fertiliser facility and completed a $275K capital raise, while deferring field trials to better align with cropping cycles. The company is also undergoing significant restructuring to improve capital efficiency and focus on strategic growth.

Codeifai Limited has raised $2.35 million through a share placement to fund key acquisitions and expand its footprint in quantum computing and AI. The move signals a strategic push towards U.S. market engagement and commercialisation of cutting-edge technology.

Cynata Therapeutics is advancing three pivotal clinical trials targeting acute Graft versus Host Disease, osteoarthritis, and kidney transplantation, with major results expected through early 2026. The company maintains a solid cash position supporting its clinical pipeline and strategic growth.

Felix Gold is advancing its Treasure Creek Project in Alaska, aiming for the first domestic antimony concentrate production in over 30 years by late 2025 or early 2026, supported by strong government engagement and solid finances.

Grand Gulf Energy has secured an exclusive option for a major offshore Namibia oil block with over a billion barrels prospective resource and signed a strategic MoU to jointly explore helium and potash in Utah’s Paradox Basin.

RocketDNA reported steady revenue for the June 2025 quarter while significantly expanding its autonomous drone services across Australia, Africa, and Papua New Guinea. New contracts and operational milestones underscore its growing footprint in mining and government sectors.

OncoSil Medical has reported a record 20% quarterly increase in dose sales and secured $8.7 million in new capital, underpinning its clinical and commercial expansion in pancreatic cancer treatment.